TP53 and hepatocellular carcinoma: Liao et al. investigated the mutational profile of these three genes in a cohort of Chinese HCC patients and identified TERT, CTNNB1 and TP53 mutations in 4.9%, 9.8% and 4.9%, respectively, of serum samples [26].